Combination Temsirolimus and Lenalidomide Seems Feasible in Relapsed/Refractory Lymphomas
Researchers sought to determine whether combination therapy with temsirolimus and lenalidomide would have therapeutic activity in patients with heavily pretreated lymphomas.